Skip to main content

Hewes L. Becker's Form 4 filing

Blueprint Medicines Corp (BPMC) · filed Jun 4, 2024

Accession no.
0001415889-24-015315
Filed
Jun 4, 2024
Trade date
May 31-Jun 3, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 9 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.14M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hewes L. BeckerCIK 0001840110Officer (CHIEF MEDICAL OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 31, 2024Common StockMOption exerciseAcquired+10,573$66.24+$700,355.5256,854Direct
May 31, 2024Common StockMOption exerciseAcquired+8,385$61.31+$514,084.3565,239Direct
May 31, 2024Common StockMOption exerciseAcquired+5,729$43.15+$247,206.3570,968Direct
May 31, 2024Common StockSSaleDisposed−3,671$107.86−$395,954.0667,297Direct
May 31, 2024Common StockSSaleDisposed−3,191$106.50−$339,841.564,106Direct
May 31, 2024Common StockSSaleDisposed−20,904$105.81−$2,211,852.2443,202Direct
May 31, 2024Common StockSSaleDisposed−6,342$104.83−$664,831.8636,860Direct
Jun 3, 2024Common StockSSaleDisposed−2,971$106.43−$316,203.5333,889Direct
Jun 3, 2024Common StockSSaleDisposed−1,951$106.43−$207,644.9331,938Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 31, 2024Common StockMOption exerciseDisposed−10,573$0.00$013,490Direct
May 31, 2024Common StockMOption exerciseDisposed−8,385$0.00$09,115Direct
May 31, 2024Common StockMOption exerciseDisposed−5,729$0.00$019,271Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)